EyeGene, Inc. (185490) Price & Analysis

― Followers

185490 Stock Chart & Stats

₩2020.00

₩30.00(1.51%)

Sep 07, 2026

―

Day’s Range― - ―

52-Week Range₩1,182.00 - ₩2,805.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)211.52K

Market Cap

₩86.01B

Enterprise Value₩17.99K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.06

Next Earnings

Nov 16, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-86.78

Shares Outstanding43,229,782

10 Day Avg. Volume135,587

30 Day Avg. Volume211,519

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

185490 FAQ

What was EyeGene, Inc.’s price range in the past 12 months?

EyeGene, Inc. lowest stock price was ₩1182.00 and its highest was ₩2805.00 in the past 12 months.

What is EyeGene, Inc.’s market cap?

EyeGene, Inc.’s market cap is ₩86.01B.

When is EyeGene, Inc.’s upcoming earnings report date?

EyeGene, Inc.’s upcoming earnings report date is Nov 16, 2026 which is in 69 days.

How were EyeGene, Inc.’s earnings last quarter?

EyeGene, Inc. released its earnings results on Aug 14, 2026. The company reported -₩86.778 earnings per share for the quarter.

Is EyeGene, Inc. overvalued?

According to Wall Street analysts EyeGene, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does EyeGene, Inc. pay dividends?

EyeGene, Inc. does not currently pay dividends.

What is EyeGene, Inc.’s EPS estimate?

EyeGene, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EyeGene, Inc. have?

EyeGene, Inc. has 43,229,782 shares outstanding.

What happened to EyeGene, Inc.’s price movement after its last earnings report?

EyeGene, Inc. reported an EPS of -₩86.778 in its last earnings report. Following the earnings report the stock price went down -0.739%.

Which hedge fund is a major shareholder of EyeGene, Inc.?

Currently, no hedge funds are holding shares in KR:185490

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology